Gene therapy targeting nuclear factor-kappaB: towards clinical application in inflammatory diseases and cancer.
about
Advances in rheumatology: new targeted therapeuticsCell-type specific penetrating peptides: therapeutic promises and challengesSecretory phospholipase A2-IIa upregulates HER/HER2-elicited signaling in lung cancer cells.NF-κB-inducing kinase is a key regulator of inflammation-induced and tumour-associated angiogenesis.Gene therapy-mediated reprogramming tumor infiltrating T cells using IL-2 and inhibiting NF-κB signaling improves the efficacy of immunotherapy in a brain cancer modelsiRNA: a new approach to target neuropathic pain.NF-κB in colorectal cancer.Chronic inflammation in biomaterial-induced periprosthetic osteolysis: NF-κB as a therapeutic target.Novel biological strategies for treatment of wear particle-induced periprosthetic osteolysis of orthopaedic implants for joint replacement.Nanodrug delivery in reversing multidrug resistance in cancer cells.Ageing, metabolism and cardiovascular disease.Molecular Pathways: Revisiting Glycogen Synthase Kinase-3β as a Target for the Treatment of Cancer.N-acetylcysteine improves antitumoural response of Interferon alpha by NF-kB downregulation in liver cancer cells.Xanthotoxol exerts neuroprotective effects via suppression of the inflammatory response in a rat model of focal cerebral ischemia.Suppression of chronic inflammation with engineered nanomaterials delivering nuclear factor κB transcription factor decoy oligodeoxynucleotides.Redox Paradox: A novel approach to therapeutics-resistant cancer.CD64: An Attractive Immunotherapeutic Target for M1-type Macrophage Mediated Chronic Inflammatory Diseases.Aberrant expression of glycogen synthase kinase-3β in human breast and head and neck cancerRepurposing Thioridazine (TDZ) as an anti-inflammatory agent
P2860
Q21093257-06CA23CF-034F-4152-B6B8-9929F0FCEF5BQ26800103-2B91D119-2E7E-4D30-810A-6D492CA3A9F0Q34000586-02880A23-C4E4-44B5-A877-8EA99AFEEE03Q34324711-E3B466E2-72D2-4EF5-84AC-9E2AE7E01F9DQ36345439-F8F7F1E0-6E23-44A2-8DE4-E58A62A3D271Q38051429-11F91E6B-29D5-4680-B279-56989F6AE656Q38103447-920C0195-3F8D-48AF-AE1D-FD112AC7FF29Q38148877-DB34DC96-93A3-449E-913B-41044012C66EQ38183358-7A54A672-2936-4655-BDD9-F1A736585D86Q38234908-104CD98F-389A-4B82-B5D2-77705403DDAEQ38590519-61DD4DEF-76DB-4B95-B1CE-9B9CC5E525C9Q39067484-D6EF377B-8E73-4788-955F-7FC416F6D783Q41880643-B5D07D88-DB9B-4714-BDC6-7A82AAC7CAF3Q44726446-8643E625-018A-4CC4-BCB2-7DBE510644CFQ47859509-8F77949A-4050-4F38-B327-C5C8B48FB641Q50082485-2672C94A-6397-4390-8CD0-B67ED009585DQ53076778-BFABEB65-CE27-4A7A-83E1-96F839EAE8A2Q58572626-AFF330BF-D1C9-4C16-8BE3-9EF291E1EF54Q58765520-2BD9A556-17C3-4679-AD9B-6CB74DC7DD8B
P2860
Gene therapy targeting nuclear factor-kappaB: towards clinical application in inflammatory diseases and cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Gene therapy targeting nuclear ...... lammatory diseases and cancer.
@en
Gene therapy targeting nuclear ...... lammatory diseases and cancer.
@nl
type
label
Gene therapy targeting nuclear ...... lammatory diseases and cancer.
@en
Gene therapy targeting nuclear ...... lammatory diseases and cancer.
@nl
prefLabel
Gene therapy targeting nuclear ...... lammatory diseases and cancer.
@en
Gene therapy targeting nuclear ...... lammatory diseases and cancer.
@nl
P2093
P2860
P921
P1433
P1476
Gene therapy targeting nuclear ...... lammatory diseases and cancer.
@en
P2093
Margriet J B M Vervoordeldonk
Paul P Tak
Sander W Tas
P2860
P304
P356
10.2174/156652309788488569
P407
P5008
P577
2009-06-01T00:00:00Z